ClinicalTrials.gg
RecruitingNCT06956417REMEMBRUpdated Jun 2, 2026

REhabilitation of MEMory Symptoms After BRain Concussion

An interventional study of Cognitive behavioral therapy and Cognitive rehabilitation in Concussion, Brain and Mild Traumatic Brain Injury, sponsored by University of British Columbia. Recruiting at 8 sites in Canada. Open to participants aged 18 Years to 59 Years. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
184
Allocation
Randomized
Ages
18 Years to 59 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 13 studies in Brain Concussion by University of British Columbia — 2 open to participants now, 3 under way, none of them phase 3. Brain Concussion · University of British Columbia.

Planned enrollment
3rd of 13
184 · median 64
Started
2025
the only one that year
No phase
12 of 13
2 open now
Registered
13th of 13
by date

Among the 13 studies in Brain Concussion by University of British Columbia, this one is the 3rd largest by planned enrollment, is the only one that started in 2025, is one of 12 with no phase, and was the 13th registered.

Brain Concussion

637 studies on the registry are indexed under Brain Concussion; 163 are open to participants now.

Browse Brain Concussion studies →

Open to participants now

2 of the 13 studies in Brain Concussion by University of British Columbia are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 112 Brain Concussion studies recruiting now, 33 (29%) set no upper age limit and 72 (64%) stop at 75 or younger; 24 take children under 18; 38 take healthy volunteers.

This study: 18 Years to 59 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Brain Concussion by University of British Columbia, or all of them as a file.
02

Study summary

Persistent memory symptoms after concussion are common, and likely perpetuated by unhelpful illness beliefs and coping behaviors. Results from a pilot study suggested that traditional cognitive rehabilitation and a novel cognitive-behavioral therapy (CBT) protocol were both associated with improvements in subjective memory functioning. The present study will more definitively compare the effectiveness of these interventions for improving subjective memory functioning after concussion.

Read the detailed description

The primary research aims of this study are to determine whether cognitive behavioral therapy (CBT) and cognitive compensatory strategy training (CCST) improves subjective memory functioning compared to usual care, and to compare the effectiveness of CBT and CCST. This study is a multisite three-armed randomized control trial (RCT) that will randomize adults with persistent memory symptoms following concussion to CBT, CCST, or a covert waitlist condition (2:2:1). Participants will be blinded to the other arms of the study and the study hypotheses.

03

Conditions studied

  • Concussion, Brain
  • Mild Traumatic Brain Injury

Browse trials for

Keywords

  • Functional cognitive disorder
04

Who can participate

Ages eligible
18 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18-59
  2. Concussion diagnosis confirmed with structured interview based on American Congress of Rehabilitation Medicine diagnostic criteria
  3. Concussion occurred between 6 and 36 months before enrollment
  4. Ongoing memory concerns
  5. Fluent in English
  6. Stable access to a computer, tablet, or smartphone with internet capability

Exclusion criteria

Exclusion Criteria:

  1. Fail performance validity testing
  2. Comorbid psychiatric or neurological disorder or is taking a medication that could fully account for their memory symptoms
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
184 participants (estimated)

Study arms

  • Experimental
    Cognitive behavioral therapy

    Behavioral: Cognitive behavioral therapy

  • Active comparator
    Cognitive rehabilitation

    Behavioral: Cognitive rehabilitation

  • No intervention
    Waitlist - Usual care

Interventions

  • BehavioralCognitive behavioral therapy

    Cognitive behavioral therapy (CBT) is delivered by a psychologist over 10 individual (1:1) manualized videoconference sessions. The goal of this therapy is for participants to use their memory more normally (i.e., reduce avoidance and safety behaviors) and view memory lapses as less threatening.

  • BehavioralCognitive rehabilitation

    Cognitive compensatory strategy training (CCST), a traditional cognitive rehabilitation intervention, is delivered by a Occupational Therapist over 10 individual (1:1) manualized videoconference sessions. Participants optimize their use of current compensatory strategies and/or learn new ones suited to their needs and lifestyle. The goal is to minimize memory lapses in daily life.

06

What researchers measure

Primary outcomes

  1. Multifactorial Memory Questionnaire-Satisfaction scale

    Measures participants' concern, satisfaction, and overall appraisal of their memory ability. Participants rate their agreement with 18 statements. Total scores range from 0 to 72, with lower total scores indicating worse subjective memory functioning.

    Time frame: Week 20

Secondary outcomes

  1. Fear-Avoidance of Memory Loss Scale

    Assesses fears and avoidance behaviors associated with memory decline. Participants rate 24 items on a 5-point scale, where the higher scores indicate greater memory concern and maladaptive coping.

    Time frame: Week 1 and week 20

  2. Patient Global Impression of Change scale

    Participants rate how much their memory functioning has improved or declined overall since the beginning of the study, on a single item rated on a 7-point scale where the midpoint is no change.

    Time frame: Week 20

  3. Work and Social Adjustment Scale

    Participants rate how much their condition interferes with their ability to carry out occupational and social activities across 5 items, on a scale from 1-7 where higher scores indicate more difficulty.

    Time frame: Week 1 and week 20

07

Study locations

7 of 8 sites recruiting
  • Calgary Brain Injury Program
    Calgary, Alberta T2N 2T9, Canada
    Recruiting
  • Fraser Health Acquired Brain Injury and Concussion Services
    Langley, British Columbia V1M 4A6, Canada
    Recruiting
  • G.F. Strong Adult Concussion Services
    Vancouver, British Columbia V5Z 2G9, Canada
    Recruiting
  • Integrated Adult Concussion Program at Hamilton Health Sciences
    Hamilton, Ontario L8N 3Z5, Canada
    Active, not recruiting

    Not enrolling at this site.

  • 360 Concussion Care Clinic
    Ottawa, Ontario K1H 7X7, Canada
    Recruiting
  • Sunnybrook Traumatic Brain Injury Clinic
    Toronto, Ontario M4N 3M5, Canada
    Recruiting
  • Hull-Ellis Concussion and Research Clinic at University Health Network
    Toronto, Ontario M5G 2A2, Canada
    Recruiting
  • Canadian Concussion Centre at Toronto Western Hospital
    Toronto, Ontario M5T 2S8, Canada
    Recruiting
08

References and documents

Publications

  • Rioux M, Mamman R, Byworth MT, Panenka WJ, Howard AK, Perez DL, Schmidt J, Courchesne C, LeMoult J, Heran MK, Silverberg ND. Pilot feasibility randomised controlled trial of cognitive-behavioural therapy for functional cognitive disorder after concussion. BMJ Neurol Open. 2024 Oct 11;6(2):e000666. doi: 10.1136/bmjno-2024-000666. eCollection 2024. PubMed 39410977 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Apr 2028, 33 months after the start.

Of 248 non-industry interventional studies with no phase under Brain Concussion, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 47. This study's planned 33 months is above that.

Counting every sponsor, half of 264 studies reached it within 28 months; a quarter within 19 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2025
First posted
May 4, 2025
StartActual
Jul 2, 2025
Primary completionEst.
Apr 30, 2028
CompletionEst.
Apr 30, 2029
Last update
Jun 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06956417
Responsible party
Noah Silverberg (Principal Investigator, University of British Columbia) — Principal investigator
First posted
May 4, 2025
Start date
Jul 2, 2025
Primary completion
Apr 30, 2028 (estimated)
Completion
Apr 30, 2029 (estimated)
Last update
Jun 2, 2026

Study contacts

Noah D Silverberg, PhD
Contact
noah.silverberg@ubc.ca
6047341313 ext. 2316
Tasha L Klotz, BA
Contact
tasha.klotz@ubc.ca
6047341313 ext. 2316
Noah D Silverberg, PhD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion